Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells

For the past several decades, research in understanding the molecular basis of human aging has progressed significantly with the analysis of premature aging syndromes. Progerin, an altered form of lamin A, has been identified as the cause of premature aging in Hutchinson-Gilford Progeria Syndrome (HGPS), and may be a contributing causative factor in normal aging. However, the question of whether HGPS actually recapitulates the normal aging process at the cellular and organismal level, or simply mimics the aging phenotype is widely debated. In the present study we analyzed publicly available microarray datasets for fibroblasts undergoing cellular aging in culture, as well as fibroblasts derived from young, middle-age, and old-age individuals, and patients with HGPS. Using GeroScope pathway analysis and drug discovery platform we analyzed the activation states of 65 major cellular signaling pathways. Our analysis reveals that signaling pathway activation states in cells derived from chronologically young patients with HGPS strongly resemble cells taken from normal middle-aged and old individuals. This clearly indicates that HGPS may truly represent accelerated aging, rather than being just a simulacrum. Our data also points to potential pathways that could be targeted to develop drugs and drug combinations for both HGPS and normal aging.

[1]  G. Fisher,et al.  UV-light-induced signal cascades and skin aging , 2002, Ageing Research Reviews.

[2]  Béatrice Desvergne,et al.  From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. , 2006, Progress in lipid research.

[3]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[4]  I. Varela,et al.  From Immature Lamin to Premature Aging: Molecular Pathways and Therapeutic Opportunities , 2005, Cell Cycle.

[5]  Y. Zou,et al.  DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A , 2006, Journal of Cell Science.

[6]  Rafael A. Irizarry,et al.  A framework for oligonucleotide microarray preprocessing , 2010, Bioinform..

[7]  T. Misteli,et al.  The central role of chromatin maintenance in aging , 2009, Aging.

[8]  O. Dreesen,et al.  Accelerated aging syndromes, are they relevant to normal human aging? , 2011, Aging.

[9]  C. Mammucari,et al.  Signaling pathways in mitochondrial dysfunction and aging , 2010, Mechanisms of Ageing and Development.

[10]  David J. Chen,et al.  Genomic instability in laminopathy-based premature aging , 2005, Nature Medicine.

[11]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[12]  L. Terracciano,et al.  Discordant Gene Expression Signatures and Related Phenotypic Differences in Lamin A- and A/C-Related Hutchinson-Gilford Progeria Syndrome (HGPS) , 2011, PloS one.

[13]  Atul J Butte,et al.  Genome‐scale expression profiling of Hutchinson–Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis , 2004, Aging cell.

[14]  T. Misteli,et al.  Mapping of lamin A- and progerin-interacting genome regions , 2012, Chromosoma.

[15]  U. Aebi,et al.  Lamin A and lamin C form homodimers and coexist in higher complex forms both in the nucleoplasmic fraction and in the lamina of cultured human cells , 2011, Nucleus.

[16]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[17]  P. Pourquier,et al.  Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancers. , 2015, Pharmacology & therapeutics.

[18]  S. Adam,et al.  Nuclear lamins and chromatin: when structure meets function. , 2009, Advances in enzyme regulation.

[19]  A M Aliper,et al.  Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling , 2014, Leukemia.

[20]  Ben S. Wittner,et al.  Systems-Level Modeling of Cancer-Fibroblast Interaction , 2009, PloS one.

[21]  P. Collas,et al.  Closing the (nuclear) envelope on the genome: How nuclear lamins interact with promoters and modulate gene expression , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  Howard J Worman,et al.  The nuclear envelope as a signaling node in development and disease. , 2009, Developmental cell.

[23]  Nikolay M. Borisov,et al.  Signaling pathways activation profiles make better markers of cancer than expression of individual genes , 2014, Oncotarget.

[24]  Arlan Richardson,et al.  Caspase-2 deficiency enhances aging-related traits in mice , 2007, Mechanisms of Ageing and Development.

[25]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[26]  Nikolay M. Borisov,et al.  Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs , 2014, Front. Genet..

[27]  M. Blagosklonny.  Progeria, rapamycin and normal aging: recent breakthrough , 2011, Aging.

[28]  A. Wells,et al.  Aging Fibroblasts Present Reduced Epidermal Growth Factor (EGF) Responsiveness Due to Preferential Loss of EGF Receptors* , 2000, The Journal of Biological Chemistry.

[29]  F. Collins,et al.  Cardiovascular Pathology in Hutchinson-Gilford Progeria: Correlation With the Vascular Pathology of Aging , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Y. Zou,et al.  Genomic Instability and DNA Damage Responses in Progeria Arising from Defective Maturation of Prelamin A , 2009, Aging.

[31]  Pierre Cau,et al.  Lamin A Truncation in Hutchinson-Gilford Progeria , 2003, Science.

[32]  F L DeBusk,et al.  The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. , 1972, The Journal of pediatrics.

[33]  S. Wellek.  Testing Statistical Hypotheses of Equivalence and Noninferiority , 2010 .

[34]  Nikolay M. Borisov,et al.  The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis , 2014, Front. Mol. Biosci..

[35]  Amar Singh Bhukya,et al.  Hutchinson-Gilford progeria syndrome , 2015, Indian dermatology online journal.

[36]  G. Poli,et al.  Alternate-day fasting reverses the age-associated hypertrophy phenotype in rat heart by influencing the ERK and PI3K signaling pathways , 2011, Mechanisms of Ageing and Development.

[37]  Chao Dai,et al.  Inducing Pairwise Gene Interactions from Time-Series Data by EDA Based Bayesian Network , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.

[38]  M. Horan,et al.  The effects of ageing on cutaneous wound healing in mammals. , 1995, Journal of anatomy.

[39]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[40]  Laura Scott,et al.  Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome , 2003, Nature.

[41]  J. Chung,et al.  Alteration of the TGF-β/SMAD pathway in intrinsically and UV-induced skin aging , 2005, Mechanisms of Ageing and Development.

[42]  B. van Steensel,et al.  Genome-nuclear lamina interactions and gene regulation. , 2010, Current opinion in cell biology.

[43]  K. Kaestner,et al.  The International Journal of Biochemistry & Cell Biology. Preface. , 2011, The international journal of biochemistry & cell biology.

[44]  H. Tanke,et al.  Microarray-based identification of age-dependent differences in gene expression of human dermal fibroblasts , 2012, Mechanisms of Ageing and Development.

[45]  K. Köhrer,et al.  Inadequate mito-biogenesis in primary dermal fibroblasts from old humans is associated with impairment of PGC1A-independent stimulation , 2014, Experimental Gerontology.

[46]  P. Bender,et al.  Cell autonomous expression of inflammatory genes in biologically aged fibroblasts associated with elevated NF-kappaB activity , 2008, Immunity & Ageing.

[47]  M. Cesari,et al.  Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. , 2013, The international journal of biochemistry & cell biology.

[48]  S. O’Donoghue,et al.  Defective Lamin A-Rb Signaling in Hutchinson-Gilford Progeria Syndrome and Reversal by Farnesyltransferase Inhibition , 2010, PloS one.

[49]  Nikolay M. Borisov,et al.  Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data , 2014, Front. Genet..

[50]  Ignacio Varela,et al.  Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation , 2005, Nature.

[51]  Robert Gentleman,et al.  Network structures and algorithms in Bioconductor , 2005, Bioinform..

[52]  Linda Partridge,et al.  Extending Healthy Life Span—From Yeast to Humans , 2010, Science.

[53]  T. Johnson.  Rapid Aging Rescue? , 2013, Science.

[54]  G. Chatta,et al.  Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand , 2004, Experimental Gerontology.

[55]  Kewu Huang,et al.  Age-induced augmentation of p38 MAPK phosphorylation in mouse lung , 2011, Experimental Gerontology.

[56]  Z. Darżynkiewicz,et al.  Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling , 2012, Aging.

[57]  R. Abraham,et al.  Targeting mTOR globally in cancer: Thinking beyond rapamycin , 2009, Cell cycle.

[58]  Anthony J. Cesare,et al.  A genomics approach identifies senescence-specific gene expression regulation , 2014, Aging cell.

[59]  L. Berstein.  Metformin in obesity, cancer and aging: addressing controversies , 2012, Aging.